☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
FIDELIO-DKD Renal Outcomes Study
Bayer Reports Results of Finerenone P-III FIDELIO-DKD Renal Outcomes Study in Patients with Chronic Kidney Disease and Type 2 Diab...
July 10, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.